X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1243) 1243
Book Chapter (31) 31
Dissertation (4) 4
Book / eBook (3) 3
Book Review (2) 2
Publication (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rheumatoid arthritis (851) 851
science & technology (756) 756
life sciences & biomedicine (750) 750
humans (691) 691
rheumatology (572) 572
antirheumatic agents - therapeutic use (485) 485
arthritis, rheumatoid - drug therapy (485) 485
disease-modifying antirheumatic drugs (400) 400
female (398) 398
male (378) 378
middle aged (342) 342
adult (268) 268
treatment outcome (242) 242
aged (234) 234
arthritis (198) 198
methotrexate (186) 186
antirheumatic agents (176) 176
rheumatoid factor (166) 166
medicine & public health (161) 161
disease modifying antirheumatic drugs (148) 148
antirheumatic agents - adverse effects (147) 147
drug therapy (139) 139
pharmacology & pharmacy (133) 133
drug therapy, combination (129) 129
methotrexate - therapeutic use (125) 125
severity of illness index (122) 122
disease-modifying anti-rheumatic drugs (121) 121
internal medicine (116) 116
disease-modifying antirheumatic drug (97) 97
retrospective studies (92) 92
arthritis, rheumatoid - diagnosis (91) 91
antirheumatic agents - administration & dosage (90) 90
tumor necrosis factor-alpha - antagonists & inhibitors (89) 89
care and treatment (85) 85
general & internal medicine (83) 83
medicine, general & internal (80) 80
time factors (80) 80
risk factors (79) 79
analysis (76) 76
biological products - therapeutic use (75) 75
psoriatic arthritis (75) 75
biologics (74) 74
drugs (73) 73
immunology (70) 70
abridged index medicus (69) 69
disease progression (63) 63
patients (63) 63
etanercept (61) 61
arthritis, rheumatoid - physiopathology (60) 60
medical research (58) 58
musculoskeletal diseases (58) 58
prospective studies (56) 56
treatment (56) 56
animals (55) 55
disease modifying anti-rheumatic drugs (55) 55
medicine, experimental (54) 54
arthritis, rheumatoid - epidemiology (53) 53
adolescent (52) 52
follow-up studies (52) 52
medicine (52) 52
remission (52) 52
infliximab (51) 51
cohort studies (50) 50
arthritis, rheumatoid - blood (49) 49
orthopedics (49) 49
leflunomide (48) 48
aged, 80 and over (47) 47
anti-inflammatory agents, non-steroidal - therapeutic use (47) 47
antibodies, monoclonal - therapeutic use (47) 47
corticosteroids (47) 47
antirheumatic agents - pharmacology (46) 46
glucocorticoids (46) 46
prognosis (46) 46
randomized controlled trials as topic (46) 46
surveys and questionnaires (44) 44
arthritis, rheumatoid - immunology (43) 43
research (43) 43
skin and connective tissue diseases (43) 43
adalimumab (42) 42
arthritis, psoriatic - drug therapy (42) 42
disease activity (41) 41
health aspects (41) 41
inflammation (41) 41
clinical trials (40) 40
diseases of the musculoskeletal system (40) 40
young adult (40) 40
antirheumatic agents - economics (39) 39
disease modifying antirheumatic drug (39) 39
methotrexate - adverse effects (39) 39
biological agents (38) 38
research article (38) 38
arthritis, rheumatoid - complications (37) 37
remission induction (37) 37
arthritis, rheumatoid - economics (36) 36
dose-response relationship, drug (35) 35
quality of life (35) 35
dosage and administration (34) 34
glucocorticoids - therapeutic use (34) 34
pharmacology/toxicology (34) 34
rheumatic diseases (34) 34
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1169) 1169
German (62) 62
Russian (26) 26
Japanese (24) 24
Spanish (22) 22
Polish (11) 11
French (10) 10
Italian (6) 6
Czech (4) 4
Korean (2) 2
Portuguese (2) 2
Slovak (2) 2
Chinese (1) 1
Hungarian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2005, Progress in inflammation research, ISBN 3764365951, xiii, 343
Book
Inflammation & allergy drug targets, ISSN 1871-5281, 2014, Volume 13, Issue 4, pp. 249 - 261
Journal Article
Journal Article
Arthritis care & research (2010), ISSN 2151-464X, 06/2018, Volume 70, Issue 6, pp. 834 - 841
...‐to‐high disease activity (MHDAS) adjust disease‐modifying antirheumatic drug (DMARD) therapy at least every 3 months until reaching low disease activity or remission (LDAS... 
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Severity of Illness Index | Time Factors | Antirheumatic Agents - administration & dosage | Arthritis, Rheumatoid - drug therapy | Humans | Middle Aged | Female | Male | Registries | Aged | Remission | Rheumatoid arthritis | Geriatrics | Index Medicus | survival analysis | treatment decisions | rheumatoid arthritis | disease-modifying antirheumatic drug
Journal Article
Journal Article
Reumatologia, ISSN 0034-6233, 2019, Volume 57, Issue 4, pp. 214 - 220
Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory diseases... 
Drugs | Side effects | Biological products | Autoantibodies | Immune response | Disease | Immunodeficiency | Autoimmune diseases | Disease control | Immunosuppressive agents | Inflammatory diseases | adverse effects | biologic agents | Review Paper | biological disease-modifying antirheumatic drugs
Journal Article
Clinical therapeutics, ISSN 0149-2918, 2009, Volume 31, Issue 8, pp. 1737 - 1746
Journal Article